806 related articles for article (PubMed ID: 30073257)
41. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
Sumie S; Kuromatsu R; Okuda K; Ando E; Takata A; Fukushima N; Watanabe Y; Kojiro M; Sata M
Ann Surg Oncol; 2008 May; 15(5):1375-82. PubMed ID: 18324443
[TBL] [Abstract][Full Text] [Related]
42. Prognostic Value and Prediction of Extratumoral Microvascular Invasion for Hepatocellular Carcinoma.
Nitta H; Allard MA; Sebagh M; Ciacio O; Pittau G; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Bismuth H; Guettier C; Lewin M; Samuel D; Baba H; Adam R
Ann Surg Oncol; 2019 Aug; 26(8):2568-2576. PubMed ID: 31054040
[TBL] [Abstract][Full Text] [Related]
43. Association of Hepatitis B Virus DNA Level and Follow-up Interval With Hepatocellular Carcinoma Recurrence.
Wang W; Tian SL; Wang H; Shao CC; Wang YZ; Li YL
JAMA Netw Open; 2020 Apr; 3(4):e203707. PubMed ID: 32338753
[TBL] [Abstract][Full Text] [Related]
44. Better prognosis of hepatic resection combined with antiviral therapy for HBV-related hepatocellular carcinoma with BCLC Stage B/C.
Wei Q; Tian H; Luo HX; Zhang YC; Deng YN; Yao J; Li H; Chen GH; Yang Y
Asian J Surg; 2017 Nov; 40(6):453-462. PubMed ID: 27321176
[TBL] [Abstract][Full Text] [Related]
45. Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma.
Sohn W; Kang TW; Choi SK; Jung SH; Lee MW; Lim HK; Cho JY; Shim SG; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Rhim H; Paik YH
Oncotarget; 2016 Jul; 7(30):47794-47807. PubMed ID: 27329596
[TBL] [Abstract][Full Text] [Related]
46. Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC.
Li T; Wang SK; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Fan J
Liver Int; 2016 Feb; 36(2):284-92. PubMed ID: 26104132
[TBL] [Abstract][Full Text] [Related]
47. HBV DNA levels impact the prognosis of hepatocellular carcinoma patients with microvascular invasion.
Li L; Li B; Zhang M
Medicine (Baltimore); 2019 Jul; 98(27):e16308. PubMed ID: 31277172
[TBL] [Abstract][Full Text] [Related]
48. Antiviral therapy decreases recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection: a meta-analysis.
Zhou Y; Zhang Z; Zhao Y; Wu L; Li B
World J Surg; 2014 Sep; 38(9):2395-402. PubMed ID: 24791945
[TBL] [Abstract][Full Text] [Related]
49. Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence.
Zhang W; Lai SL; Chen J; Xie D; Wu FX; Jin GQ; Su DK
World J Gastroenterol; 2017 Sep; 23(35):6467-6473. PubMed ID: 29085196
[TBL] [Abstract][Full Text] [Related]
50. Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load.
Sinn DH; Lee J; Goo J; Kim K; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Yoo BC; Paik SW
Hepatology; 2015 Sep; 62(3):694-701. PubMed ID: 25963803
[TBL] [Abstract][Full Text] [Related]
51. Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study.
Yun B; Ahn SH; Oh J; Yoon JH; Kim BK
Eur J Intern Med; 2023 Jan; 107():66-72. PubMed ID: 36347739
[TBL] [Abstract][Full Text] [Related]
52. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load.
Sohn W; Paik YH; Cho JY; Ahn JM; Choi GS; Kim JM; Kwon CH; Joh JW; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
J Viral Hepat; 2015 Jun; 22(6):539-50. PubMed ID: 25377516
[TBL] [Abstract][Full Text] [Related]
53. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of Adjuvant Transarterial Chemoembolization Combined Antiviral Therapy for HBV-Related HCC with MVI after Hepatic Resection: A Multicenter Study.
Tang Y; Zhang J; Chen G; Zeng J; Zeng J
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2695-2703. PubMed ID: 36037123
[TBL] [Abstract][Full Text] [Related]
55. Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria.
Cha DI; Kang TW; Jeong WK; Kim JM; Choi GS; Joh JW; Yi NJ; Ahn SH
Eur Radiol; 2024 Jan; 34(1):498-508. PubMed ID: 37505248
[TBL] [Abstract][Full Text] [Related]
56. Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis.
Techathuvanan K; Srisajjakul S; Pongpaibul A; Limsrichamrern S; Charatcharoenwitthaya P; Chainuvati S; Tanwandee T; Chotiyaputta W
J Med Assoc Thai; 2015 Apr; 98(4):334-42. PubMed ID: 25958707
[TBL] [Abstract][Full Text] [Related]
57. Perioperative antiviral therapy improves the prognosis of HBV DNA-negative patients with HBV-related hepatocellular carcinoma.
Li C; Li ZC; Ma L; Li LQ; Zhong JH; Xiang BD; Gong WF
Expert Rev Gastroenterol Hepatol; 2020 Aug; 14(8):749-756. PubMed ID: 32552297
[TBL] [Abstract][Full Text] [Related]
58. Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection.
Zhao H; Chen C; Fu X; Yan X; Jia W; Mao L; Jin H; Qiu Y
Oncotarget; 2017 Jan; 8(3):5474-5486. PubMed ID: 27729623
[TBL] [Abstract][Full Text] [Related]
59. High HBV-DNA titer in surrounding liver rather than in hepatocellular carcinoma tissue predisposes to recurrence after curative surgical resection.
Choi JG; Chung YH; Kim JA; Jin YJ; Park WH; Lee D; Shim JH; Lee YS; Seo DD; Jang MK; Kim KM; Lim YS; Lee HC; Lee YS; Yu E; Lee YJ
J Clin Gastroenterol; 2012; 46(5):413-9. PubMed ID: 22105184
[TBL] [Abstract][Full Text] [Related]
60. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
Wang X; Wang W; Ma X; Lu X; Li S; Zeng M; Xu K; Yang C
Eur Radiol; 2020 Oct; 30(10):5337-5347. PubMed ID: 32385649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]